Skip to main content

Table 1 Clinical characteristics of 10 SYSUCC patients with H3 G34-mutant diffuse hemispheric gliomas

From: High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Patient 7

Patient 8

Patient 9

Patient 10

Sex/age (years)

F/14

F/18

M/16

F/20

M/25

F/23

F/23

M/13

F/21

M/21

Chef complaint

Headache, nausea and vomiting

Headache, nausea and vomiting

Weakness of right limbs

Generalized tonic clonic seizures

Generalized tonic clonic seizures

Headache, nausea and vomiting

Headache and weakness of left limbs

Dizziness and weakness of right foot

Generalized tonic clonic seizures

Weakness of left limbs

Site of lesion

Left temporal lobe

Right frontal lobe

Left parietal lobe and corpus callosum

Bilateral frontal lobe and corpus callosum

Right frontal, temporal, insular lobe and basal ganglia

Right frontal lobe, corona radiata, basal ganglia and corpus callosum

Right frontal and insular lobe

Left frontal and parietal lobe

Left frontal lobe

Right frontal and parietal lobe

Initial OP and adjuvant Tx

GTR + CCRT + TMZ#12

GTR + CCRT + TMZ#2

STR + CCRT

Biopsy + CCRT + TMZ#24 (continuously)

GTR + CCRT + TMZ#22 (continuously)

STR + CCRT

STR + CCRT

STR + CCRT + TMZ/DDP#4 + TMZ#6

GTR + CCRT + TMZ#3

GTR + Dianhydrodulcitol#12

2nd OP and adjuvant Tx

GTR + RT + TMZ#12

NA

Conservative

NA

NA

Conservative

Conservative

Conservative

STR + TG02#1

GTR

H3F3A

G34R

G34R

G34V

G34R

G34R

G34R

G34R

G34R

G34R

G34R

MGMT promoter

Methylated

Methylated

Un-methylated

Methylated

Methylated

Methylated

Methylated

Methylated

Methylated

Un-methylated

IDH

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

TERT promoter

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Wildtype

Morphology

GBM with primitive neuronal component

GBM

GBM

GBM

GBM

GBM

GBM

GBM

GBM

GBM with primitive neuronal component

Current status

Death

Alive

Death

Alive

Alive

Death

Alive

Alive

Death

Alive

OS (months)

75

24

16

21

18

6

16

13

17

20

  1. CCRT concurrent chemotherapy and radiation therapy, DDP cisplatin, GBM glioblastoma, GTR gross total resection, MGMT O6-methylguanine-DNA methyltransferase, NA not applicable, RT radiation therapy, STR subtotal resection, TMZ temozolomide